Sanofi-aventis, Innogenetics, and Inserm to collaborate on Alzheimer's disease
15-Nov-2006 -
Sanofi-aventis, Innogenetics, and Inserm, through its subsidiary called Inserm Transfert, announced the conclusion of a collaborative research agreement in the field of Alzheimer's disease. This collaboration agreement is signed for an initial period of 2 years, with an option for Sanofi-aventis ...
Alzheimer's disease
diagnostics
milestone payments
+4